Your browser is no longer supported. Please, upgrade your browser.
Settings
SCLN SciClone Pharmaceuticals, Inc. daily Stock Chart
SCLN [NASD]
SciClone Pharmaceuticals, Inc.
Index- P/E19.45 EPS (ttm)0.54 Insider Own1.00% Shs Outstand50.25M Perf Week2.52%
Market Cap530.64M Forward P/E- EPS next Y0.00 Insider Trans-5.63% Shs Float44.49M Perf Month-19.94%
Income28.40M PEG1.38 EPS next Q0.00 Inst Own82.40% Short Float6.73% Perf Quarter-20.00%
Sales160.20M P/S3.31 EPS this Y18.00% Inst Trans1.39% Short Ratio6.58 Perf Half Y32.17%
Book/sh3.82 P/B2.76 EPS next Y- ROA13.80% Target Price10.00 Perf Year14.66%
Cash/sh- P/C- EPS next 5Y14.10% ROE16.30% 52W Range6.47 - 15.03 Perf YTD14.78%
Dividend- P/FCF16.48 EPS past 5Y5.80% ROI16.20% 52W High-29.74% Beta1.75
Dividend %- Quick Ratio7.20 Sales past 5Y13.10% Gross Margin85.30% 52W Low63.21% ATR0.49
Employees590 Current Ratio7.80 Sales Q/Q8.60% Oper. Margin18.60% RSI (14)28.68 Volatility3.46% 3.48%
OptionableYes Debt/Eq0.00 EPS Q/Q-11.70% Profit Margin17.70% Rel Volume1.40 Prev Close10.41
ShortableYes LT Debt/Eq0.00 EarningsAug 08 AMC Payout0.00% Avg Volume454.62K Price10.56
Recom4.00 SMA20-12.84% SMA50-18.38% SMA2001.05% Volume634,667 Change1.44%
Nov-14-14Downgrade BWS Financial Buy → Hold $8.25 → $8
Nov-12-13Reiterated Aegis Capital Buy $9 → $8
Jul-16-13Upgrade Aegis Capital Hold → Buy $9
Sep-18-12Upgrade BWS Financial Hold → Buy $8.25
Aug-10-10Downgrade BWS Financial Buy → Hold $7.25 → $4.50
Apr-09-10Upgrade BWS Financial Hold → Buy $7.25
Jul-08-09Downgrade BWS Financial Buy → Hold $3.25
Jun-03-09Initiated ThinkEquity Buy $5
May-21-09Initiated Rodman & Renshaw Mkt Outperform $5
Sep-05-08Initiated Susquehanna Financial Neutral
Jul-28-16 06:00AM  SciClone Pharmaceuticals To Report Second Quarter 2016 Financial Results On August 9, 2016 PR Newswire
Jul-20-16 12:52PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : July 20, 2016
Jul-19-16 11:37AM  Whats the Deal With These Five Stocks Trading in Red on Tuesday? at Insider Monkey -20.81%
09:21AM  SciClone Pharmaceuticals' stock tumbles after ending discussions with acquirers at MarketWatch
06:00AM  SciClone Provides Update On Strategic Review Process PR Newswire
Jul-11-16 09:58AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : July 11, 2016
Jul-06-16 02:39PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : July 6, 2016
Jun-27-16 04:29PM  SciClone Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCLN) : June 27, 2016
Jun-24-16 09:01AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SCLN-US : June 24, 2016
Jun-15-16 12:36PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-03-16 03:40PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : June 3, 2016
03:19PM  3 Biotech Stocks Headed for New Highs (SCLN, SUPN) at Investopedia
May-24-16 03:36PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : May 24, 2016
May-23-16 02:04PM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q1, 2016 By the Numbers : May 23, 2016
May-18-16 01:04PM  SCICLONE PHARMACEUTICALS INC Financials
May-10-16 02:29PM  Edited Transcript of SCLN earnings conference call or presentation 10-May-16 12:30pm GMT -5.42%
07:34AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
07:07AM  Q1 2016 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
06:14AM  SciClone posts 1Q profit
06:00AM  SciClone Reports First Quarter 2016 Financial Results PR Newswire
May-03-16 09:05AM  3 Underfollowed Infectious Disease Stocks That Deserve More Attention at 24/7 Wall St.
Apr-25-16 06:00AM  SciClone Pharmaceuticals To Report First Quarter 2016 Financial Results On May 10, 2016 PR Newswire
Apr-16-16 09:00AM  'Mad Money' Lightning Round: Con Ed, Regeneron Are My Picks at TheStreet
Apr-01-16 04:23PM  SciClone Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals
Mar-31-16 03:50PM  Here's Why SciClone Pharmaceuticals' Shares Are Soaring 14% Today at Motley Fool +13.75%
07:21AM  SunEdison's Market Cap 'Is No Longer Representative Of The Mid-Cap Market Space'
Mar-30-16 06:24PM  WebMD Health Set to Join the S&P MidCap 400; SciClone Pharmaceuticals to Join S&P SmallCap 600 PR Newswire
06:00AM  SciClone To Present At Needham Healthcare Conference On April 13, 2016 PR Newswire
Mar-24-16 05:50PM  ETFs with exposure to SciClone Pharmaceuticals, Inc. : March 24, 2016
05:41PM  Soligenix Announces Recent Accomplishments and Year-End 2015 Financial Results at noodls
Mar-21-16 02:32PM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: Q4, 2015 By the Numbers
11:56AM  SciClone Pharmaceuticals, Inc. :SCLN-US: Earnings Analysis: 2015 By the Numbers
09:00AM  OxySure Therapeutics (OXYS) May Be Undervalued Compared to Others in Biotech Space Accesswire
Mar-11-16 01:29PM  SCICLONE PHARMACEUTICALS INC Files SEC form 10-K, Annual Report
05:01AM  SciClone posts 4Q profit
Mar-10-16 11:11PM  Edited Transcript of SCLN earnings conference call or presentation 10-Mar-16 9:30pm GMT
04:12PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports 2015 Financial Results PR Newswire
07:07AM  Q4 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Mar-08-16 02:45PM  LifeSci Capital Initiates Coverage of SciClone Accesswire
Feb-22-16 06:00AM  SciClone Pharmaceuticals To Report 2015 Financial Results On March 10, 2016 PR Newswire
Feb-08-16 08:05AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : February 8, 2016
Feb-04-16 06:29PM  [$$] SciClone Launches Strategic Review at The Wall Street Journal
05:09PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
05:01PM  SciClone Announces Final Resolution With The Securities And Exchange Commission And The Department Of Justice PR Newswire
Jan-27-16 06:00AM  SciClone To Present At BIO CEO & Investor Conference On February 9, 2016 PR Newswire
Jan-26-16 04:32PM  Soligenix Provides 2016 Business Outlook Reviews 2015 Achievements and 2016 Milestones at noodls
Jan-11-16 09:02AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
06:00AM  SciClone Announces Preliminary 2015 Revenue PR Newswire
Jan-05-16 08:46AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : January 5, 2016
Dec-21-15 12:51PM  SciClone Pharmaceuticals, Inc. Earnings Analysis: Q3, 2015 By the Numbers
06:00AM  SciClone To Pursue Development Of SGX942 In China Following Soligenix' Report Of Positive Phase 2 Preliminary Results In Oral Mucositis PR Newswire
Dec-18-15 08:00AM  Healthcare Sector Equities under the Scanner -- Zogenix, Amarin, SciClone Pharma, and PetMed Express Accesswire
Nov-27-15 09:17AM  Hedge Funds Arent Crazy About SciClone Pharmaceuticals, Inc. (SCLN) Anymore at Insider Monkey
Nov-24-15 04:18PM  Is Tristate Capital Holdings Inc (TSC) A Good Stock To Buy? at Insider Monkey
Nov-20-15 07:45AM  What's Moving the Markets - Research on Aegean Marine, REX American Resources, SciClone and Blue Nile Accesswire
Nov-17-15 11:57AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
06:00AM  SciClone To Present At 27th Annual Piper Jaffray Healthcare Conference On December 2, 2015 PR Newswire
Nov-14-15 09:20AM  7 BioHealth Movers That Cannot Be Ignored at 24/7 Wall St.
Nov-12-15 08:05AM  Moving Ahead of Averages, Technical Review - Research on Aegean Marine Petroleum Network, SciClone Pharmaceuticals, Noodles & Co, and Nuveen Floating Rate Income Opportunity Fund Accesswire -11.60%
Nov-11-15 04:26PM  SciClone Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals
01:00PM  Theravance Biopharma Posts Wider-than-Expected Q3 Loss
12:17PM  Story Stocks from Briefing.com Briefing.com
Nov-10-15 03:18PM  4 Stocks That Moved Massively After Earnings at 24/7 Wall St. +20.90%
02:16PM  Why SciClone Pharmaceuticals Is Soaring Today at Motley Fool
11:59AM  Here Is Why These Four Stocks Stand Out from the Crowd on Tuesday at Insider Monkey
03:53AM  Edited Transcript of SCLN earnings conference call or presentation 9-Nov-15 9:30pm GMT
01:16AM  Trending Now: SCLN
Nov-09-15 06:53PM  SciClone posts 3Q profit
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:11PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:05PM  SciClone Reports Third Quarter 2015 Financial Results PR Newswire
07:07AM  Q3 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Nov-05-15 08:10AM  Tracking the Market Movement - Research on SciClone Pharmaceuticals, Blue Nile, Noodles & Co. and PIMCO Strategic Income Fund Accesswire
Nov-03-15 06:00AM  SciClone To Present At Boston Biotech NY/NJ CEO Conference On November 12th PR Newswire
Oct-28-15 01:54PM  SciClone Pharmaceuticals, Inc. Value Analysis (NASDAQ:SCLN) : October 28, 2015
Oct-26-15 06:00AM  SciClone Pharmaceuticals To Report Financial Results For The Third Quarter 2015 On November 9th PR Newswire
Oct-21-15 09:03AM  SciClone Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : October 21, 2015
Sep-30-15 06:00AM  SciClone To Present At 2015 Aegis Capital Growth Conference On October 9th PR Newswire
Sep-24-15 09:00AM  Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00 Marketwired
Aug-27-15 06:00AM  SciClone To Present At Two Investor Conferences On September 10, 2015 PR Newswire
Aug-12-15 08:12PM  10-Q for SciClone Pharmaceuticals, Inc. at Company Spotlight
Aug-11-15 11:50AM  Theravance Biopharma Posts Narrower Q2 Loss, View Revised - Analyst Blog -13.04%
Aug-10-15 07:30PM  Edited Transcript of SCLN earnings conference call or presentation 10-Aug-15 8:30pm GMT
05:19PM  SciClone reports 2Q loss
04:30PM  SciClone Pharmaceuticals Inc Earnings Call scheduled for 4:30 pm ET today
04:04PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements
04:01PM  SciClone Reports Second Quarter 2015 Financial Results PR Newswire
07:07AM  Q2 2015 SciClone Pharmaceuticals Inc Earnings Release - After Market Close
Jul-23-15 09:10AM  Cancer Prevention Pharmaceuticals, Inc. Announces Appointment of Jon S. Saxe to its Board of Directors PR Newswire
06:00AM  SciClone Pharmaceuticals To Report Financial Results For The Second Quarter 2015 On August 10th PR Newswire
Jul-20-15 08:32AM  3 Reasons SciClone Pharmaceuticals (SCLN) is a Great Value Stock - Tale of the Tape
Jul-01-15 05:43PM  SciClone Shoots Out of Base, Phibro Turns Tail at Investor's Business Daily +14.46%
03:43PM  Should You Buy Surging SciClone Pharmaceuticals (SCLN), Up By 14.66% Today? at Insider Monkey
Jun-27-15 03:02AM  Edited Transcript of SCLN presentation 3-Jun-15 2:30pm GMT
Jun-20-15 03:45AM  Edited Transcript of SCLN earnings conference call or presentation 11-May-15 8:30pm GMT
Jun-17-15 04:40PM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to
Jun-16-15 09:08AM  Buy These 6 Risky Pharmaceutical Stocks for Big Upside Potential at TheStreet
May-27-15 11:54AM  SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
08:05AM  Theravance Biopharma and SciClone Pharmaceuticals Enter Into Development and Commercialization Agreement for VIBATIV(R) (Telavancin) in China Marketwired
SciClone Pharmaceuticals, Inc., a specialty pharmaceutical company, provides therapies for oncology, infectious diseases, and cardiovascular disorders in the People's Republic of China, the United States, and Hong Kong. Its lead product is ZADAXIN, which is used for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as an immune system enhancer. In addition, the company focuses on developing ZADAXIN for the treatment of sepsis. SciClone Pharmaceuticals, Inc. markets and sells ZADAXIN through distribution arrangements, local importers, and distributors. It markets and distributes products, such as DC Bead, Holoxan, Mesna, Endoxan, Methotrexate, Estracyt, Farlutal, Neucardin, ProFlow, Angiomax, and Cleviprex. The company has an agreement with MEDA Pharma GmbH & Co. KG for the development of Tramadol. SciClone Pharmaceuticals, Inc. was founded in 1989 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hawkins Richard JDirectorMay 05Option Exercise2.4630,00073,80030,000May 09 11:04 AM
Blobel FriedhelmPresident & CEOApr 11Option Exercise2.49659,8001,642,902765,792Apr 13 10:55 AM
Blobel FriedhelmPresident & CEOMar 28Option Exercise2.4910,00024,900214,412Mar 30 11:20 AM
Blobel FriedhelmPresident & CEOMar 28Sale9.2910,00092,878205,252Mar 30 11:20 AM
Blobel FriedhelmPresident & CEOMar 18Option Exercise2.4910,00024,900215,252Mar 21 02:29 PM
Blobel FriedhelmPresident & CEOMar 18Sale9.0910,00090,936205,252Mar 21 02:29 PM
Blobel FriedhelmPresident & CEOFeb 26Option Exercise2.4910,00024,900214,252Mar 01 03:41 PM
Blobel FriedhelmPresident & CEOFeb 26Sale9.9810,00099,771204,252Mar 01 03:41 PM
Blobel FriedhelmPresident & CEOJan 04Option Exercise2.49200498204,452Jan 06 01:33 PM
SAXE JON SDirectorJan 04Option Exercise2.4630,00073,800105,000Jan 06 01:40 PM
Blobel FriedhelmPresident & CEOJan 04Sale9.012001,802204,252Jan 06 01:33 PM
Blobel FriedhelmPresident & CEODec 28Option Exercise2.4910,00024,900214,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 28Sale9.1710,00091,697204,252Dec 29 12:19 PM
Blobel FriedhelmPresident & CEODec 17Option Exercise2.499,40023,406211,673Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 17Sale9.009,40084,600202,273Dec 18 05:40 PM
Blobel FriedhelmPresident & CEODec 11Option Exercise2.496001,494202,873Dec 14 05:39 PM
Blobel FriedhelmPresident & CEODec 11Sale9.006005,402202,273Dec 14 05:39 PM
Blobel FriedhelmPresident & CEODec 04Option Exercise2.4910,00024,900212,273Dec 07 11:12 AM
Blobel FriedhelmPresident & CEODec 04Sale9.2210,00092,211202,273Dec 07 11:12 AM
Xie LanVP Finance, China CFODec 03Option Exercise4.9114,16669,4938,125Dec 07 11:57 AM
Xie LanVP Finance, China CFODec 03Sale9.5014,166134,5770Dec 07 11:57 AM
Blobel FriedhelmPresident & CEONov 27Option Exercise2.4910,00024,900212,273Nov 30 04:30 PM
Blobel FriedhelmPresident & CEONov 27Sale9.2410,00092,419202,273Nov 30 04:30 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceNov 10Sale9.517,80374,2070Nov 10 05:01 PM
Cheung Wilson Wai-ShunCFO & Senior VP, FinanceAug 13Option Exercise0.0012,500012,500Aug 17 12:36 PM
Blobel FriedhelmPresident & CEOJul 31Option Exercise2.4910,00024,900212,273Aug 03 04:33 PM
Blobel FriedhelmPresident & CEOJul 31Sale9.1510,00091,515202,273Aug 03 04:33 PM